Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ala-Opas

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|July 17, 1999
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancerS Aaltomaa, P Lipponen, M Ala-Opas, et al.
The Journal of Pathology|January 30, 1999
Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-upP Lipponen, S Aaltoma, V M Kosma, et al.
European Urology|September 10, 1998
Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic valueP Lipponen, S Aaltomaa, M Eskelinen, et al.
Annales Chirurgiae Et Gynaecologiae. Supplementum|January 1, 1993
Prostakath in urinary outflow obstructionM Ala-Opas, M Talja, J Tiitinen, et al.
AJR. American Journal of Roentgenology|January 3, 2001
MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography. Fast low-angle shotM Sudah, R Vanninen, K Partanen, et al.
European Urology|January 1, 1997
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancerS Aaltomaa, P Lipponen, S Vesalainen, et al.
British Journal of Cancer|September 2, 1999
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survivalS Aaltomaa, P Lipponen, M Ala-Opas, et al.
European Urology|November 30, 2000
Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomyS Aaltomaa, P Lipponen, J Viitanen, et al.
Journal of Endourology|April 23, 1999
New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: an experimental studyJ Lumiaho, A Heino, V Tunninen, et al.
The Journal of Urology|September 19, 2000
The morphological, in situ effects of a self-reinforced bioabsorbable polylactide (SR-PLA 96) ureteric stent; an experimental studyJ Lumiaho, A Heino, T Pietiläinen, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|July 17, 1999
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancerS Aaltomaa, P Lipponen, M Ala-Opas, et al.
The Journal of Pathology|January 30, 1999
Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-upP Lipponen, S Aaltoma, V M Kosma, et al.
European Urology|September 10, 1998
Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic valueP Lipponen, S Aaltomaa, M Eskelinen, et al.
Annales Chirurgiae Et Gynaecologiae. Supplementum|January 1, 1993
Prostakath in urinary outflow obstructionM Ala-Opas, M Talja, J Tiitinen, et al.
AJR. American Journal of Roentgenology|January 3, 2001
MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography. Fast low-angle shotM Sudah, R Vanninen, K Partanen, et al.
European Urology|January 1, 1997
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancerS Aaltomaa, P Lipponen, S Vesalainen, et al.
British Journal of Cancer|September 2, 1999
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survivalS Aaltomaa, P Lipponen, M Ala-Opas, et al.
European Urology|November 30, 2000
Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomyS Aaltomaa, P Lipponen, J Viitanen, et al.
Journal of Endourology|April 23, 1999
New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: an experimental studyJ Lumiaho, A Heino, V Tunninen, et al.
The Journal of Urology|September 19, 2000
The morphological, in situ effects of a self-reinforced bioabsorbable polylactide (SR-PLA 96) ureteric stent; an experimental studyJ Lumiaho, A Heino, T Pietiläinen, et al.
Pageof 5